Zobrazeno 1 - 3
of 3
pro vyhledávání: '"A. L. Burdeynaya"'
Autor:
A. L. Burdeynaya, O. I. Afanasyeva, E. A. Klesareva, N. A. Tmoyan, O. A. Razova, M. I. Afanasyeva, M. V. Ezhov, S. N. Pokrovsky
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 20, Iss 2 (2021)
Aim. To study the relationship between the concentration of lipoprotein (a) (Lp (a)) and autotaxin (ATX) in patients with and without degenerative aortic valve stenosis (AoS) in the presence of coronary artery disease (CAD).Material and methods. The
Externí odkaz:
https://doaj.org/article/cdab7e24474445198c80c3865095a0df
Autor:
Anna L. Burdeynaya, Olga I. Afanasieva, Marat V. Ezhov, Elena A. Klesareva, Marina A. Saidova, Sergey N. Pokrovsky
Publikováno v:
Diseases, Vol 11, Iss 1, p 43 (2023)
Aortic valve stenosis is the most common valvular heart disease in the Western world. Lipoprotein(a) (Lp(a)) is an independent risk factor of coronary heart disease (CHD) and calcific aortic valve stenosis (CAVS). The aim of this study was to assess
Externí odkaz:
https://doaj.org/article/9e93e85413bf457a9e3574e81399d99e
Autor:
O. I. Afansieva, N. A. Tmojan, E. A. Klesareva, O. A. Razova, M. A. Afanasieva, А. L. Burdeynaya, M. A. Saidova, M. V. Ezhov, S. N. Pokrovsky
Publikováno v:
Российский кардиологический журнал, Vol 0, Iss 9, Pp 17-22 (2018)
Raised level of lipoproteide (a) (Lpa) is an independent risk factor of coronary heart disease (CHD) and is also a monogenic predictor (there is growth of prevalence) of aortic stenosis (AS) with the increase of Lpa in population. Lysophosphatide aci
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92f945f7c89032833df7a66000f897de
https://doi.org/10.15829/1560-4071-2018-9-17-22
https://doi.org/10.15829/1560-4071-2018-9-17-22